Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Rydyznski Moderbacher, Carolyn, Ramirez, Sydney I., Dan, Jennifer M., Grifoni, Alba, Hastie, Kathryn M., Weiskopf, Daniela, Belanger, Simon, Abbott, Robert K. +16 more·2020·Cell
DOI 10.1016/j.cell.2020.09.038

Cited by (1,001)

Items 601–700 of 1,001

  1. Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection
    Elham Khatamzas, Markus H. Antwerpen, Alexandra Rehn, Alexander Graf, Johannes C. Hellmuth, Alexandra Hollaus, Anne‐Wiebe Mohr, Erik Gaitzsch, Tobias Weiglein, Enrico Georgi et al. · 2022 · Nature Communications
  2. Atypical lymphoid cells circulating in blood in COVID-19 infection: morphology, immunophenotype and prognosis value
    Anna Merino, Alexandru Daniel Vlagea, Ángel Molina, Natalia Egri, Javier Laguna, Kevin Barrera, Laura Boldú, Andrea Acevedo, Mar Díaz-Pavón, Francesc Sibina et al. · 2020 · Journal of Clinical Pathology
  3. Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19
    Shuangyan Li, Fuxiaonan Zhao, Jing Ye, Kuan Li, Qi Wang, Zhongchao Du, Qing Yue, Sisi Wang, Qi Wu, Huaiyong Chen · 2022 · Medical Microbiology and Immunology
  4. Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity
    Elsa Brunet‐Ratnasingham, Sacha Morin, Haley E. Randolph, Marjorie Labrecque, Justin Bélair, Raphaël Lima-Barbosa, Amélie Pagliuzza, Lorie Marchitto, Michael Hultström, Julia Niessl et al. · 2024 · Nature Communications
  5. SARS-CoV-2 spike-specific nasal-resident CD49a+CD8+ memory T cells exert immediate effector functions with enhanced IFN-γ production
    Min‐Seok Rha, Gyeongyeob Kim, Sol Lee, Jihye Kim, Yeonsu Jeong, Chan Min Jung, Hae Eun Noh, Ji Yun Noh, Yong Min Kim, Hyung‐Ju Cho et al. · 2024 · Nature Communications
  6. Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19
    Anthony Joseph Leonardi, Rui B. Proenca · 2020 · Frontiers in Immunology
  7. Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study
    Jingyi Yang, Maohua Zhong, Ke Hong, Qingyu Yang, Ejuan Zhang, Dihan Zhou, Jianbo Xia, Yao‐qing Chen, Mingbo Sun, Bali Zhao et al. · 2021 · Clinical & Translational Immunology
  8. Immunity after SARS-CoV-2 infections
    Prasanna Jagannathan, Taia T. Wang · 2021 · Nature Immunology
  9. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19
    Collins N. Khwatenge, Marquette Pate, Laura C. Miller, Yongming Sang · 2021 · Frontiers in Immunology
  10. Epidemiological and Immunological Features of Obesity and SARS-CoV-2
    Eric James Nilles, Sameed M. Siddiqui, Stephanie Fischinger, Yannic C. Bartsch, Michael de St. Aubin, Guohai Zhou, Matthew J. Gluck, Samuel Berger, Justin Rhee, Eric Petersen et al. · 2021 · Viruses
  11. COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
    Biswajit Kumar Biswas, Shagnik Chattopadhyay, Sayantee Hazra, Arman Kunwar Hansda, Ritobrata Goswami · 2022 · Inflammation Research
  12. Helminth antigens differentially modulate the activation of CD4+ and CD8+ T lymphocytes of convalescent COVID-19 patients in vitro
    Tomabu Adjobimey, Julia Meyer, Vedrana Terkeš, Marijo Parčina, Achim M. Hoerauf · 2022 · BMC Medicine
  13. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals
    Maarten E. Emmelot, Martijn W. Vos, Mardi C. Boer, Nynke Y. Rots, Jelle de Wit, Cécile A. C. M. van Els, Patricia Kaaijk · 2022 · Viruses
  14. High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
    Anders Aune Tveita, Sarah Louise Murphy, Jan Cato Holter, Anders Benjamin Kildal, Annika Elisabet Michelsen, Tøri Vigeland Lerum, Mari Kaarbø, Lars Heggelund, Aleksander Rygh Holten, Ane‐Kristine Finbråten et al. · 2022 · The Journal of Infectious Diseases
  15. Parallel detection of SARS‐CoV ‐2 epitopes reveals dynamic immunodominance profiles of CD8 + T memory cells in convalescent COVID ‐19 donors
    Jet van den Dijssel, Ruth R. Hagen, Rivka de Jongh, Maurice Steenhuis, Theo Rispens, Dionne M. Geerdes, Juk Yee Mok, Angela HM. Kragten, Mariël C Duurland, Niels J. M. Verstegen et al. · 2022 · Clinical & Translational Immunology
  16. Atypical and non-classical CD45RBlo memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19
    David G. Priest, Takeshi Ebihara, Janyerkye Tulyeu, Jonas Nørskov Søndergaard, Shuhei Sakakibara, Fuminori Sugihara, Shunichiro Nakao, Yuki Togami, Jumpei Yoshimura, Hiroshi Ito et al. · 2024 · Nature Communications
  17. CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment
    Meenakshi Kar, Katherine Johnson, Abigail Vanderheiden, Elizabeth J. Elrod, Katharine A. Floyd, Elizabeth Geerling, E. Taylor Stone, Eduardo Salinas, Stephanie Banakis, Wei Wang et al. · 2024 · Science Advances
  18. Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study
    Lu M. Yang, Cristina Costales, Muthukumar Ramanathan, Philip L. Bulterys, Kanagavel Murugesan, Joseph G. Schroers‐Martin, Ash A. Alizadeh, Scott Dexter Boyd, Janice Wes Brown, Kari Christine Nadeau et al. · 2022 · Journal of Clinical Virology
  19. Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients
    Catherine Diefenbach, Jessica Caro, Akiko Koide, Michael L. Grossbard, Judith D. Goldberg, Bruce G. Raphael, Kenneth B. Hymes, Tibor Moskovits, Maxim Kreditor, David Kaminetzky et al. · 2021 · medRxiv
  20. Unveiling the Mysteries of Long COVID Syndrome: Exploring the Distinct Tissue and Organ Pathologies Linked to Prolonged COVID-19 Symptoms
    Fnu Sapna, Fnu Deepa, Fnu Sakshi, Fnu Sonam, FNU Kiran, Raja Sandeep Perkash, Ahmed Bendari, Anish Kumar, Yusra Rizvi, Fnu Suraksha et al. · 2023 · Cureus
  21. Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
    Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, Vana I. Spoulou · 2024 · Vaccines
  22. T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
    Samuele Notarbartolo · 2024 · Vaccines
  23. Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward
    Vipin M. Vashishtha, Puneet Kumar · 2020 · Human Vaccines & Immunotherapeutics
  24. The role of T‐cell immunity in COVID‐19 severity amongst people living with type II diabetes
    Zhen Wei Marcus Tong, Emma J. Grant, Stéphanie Gras, Melanie Wu, Corey Smith, Helen L. Barrett, Linda A. Gallo, Kirsty Renfree Short · 2021 · FEBS Journal
  25. Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence
    Riccardo Sarzani, Francesco Spannella, Federico Giulietti, Chiara Di Pentima, Piero Giordano, Andrea Giacometti · 2021 · Internal and Emergency Medicine
  26. SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection
    Susan R. Conway, Christopher A. Lazarski, Naomi E. Field, Mariah A. Jensen-Wachspress, Haili Lang, Vaishnavi V. Kankate, Jessica R. Durkee-Shock, Hannah Kinoshita, William Suslovic, Kathleen Webber et al. · 2022 · Frontiers in Immunology
  27. Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19
    Vidisha Singh, Veronica Obregon-Perko, Stacey A. Lapp, Anna M. Horner, Alyssa D. Brooks, Lisa Macoy, Laila Hussaini, Austin Lu, Theda Gibson, Guido Silvestri et al. · 2022 · JCI Insight
  28. Evaluation of the Levels of Peripheral CD3 + , CD4 + , and CD8 + T Cells and IgG and IgM Antibodies in COVID-19 Patients at Different Stages of Infection
    Waleed A. Aljabr, Ahod Al-Amari, Basma Abbas, Alaa Karkashan, Saad Saeed Alamri, Mohammed Alnamnakani, Athba Alqahtani · 2022 · Microbiology Spectrum
  29. Immune responses to SARS-CoV-2 in dialysis and kidney transplantation
    Chiara Cantarelli, Andrea Angeletti, Laura Perin, Luis Sanchez Russo, Gianmarco Sabiu, Manuel Alfredo Podestà, Paolo Cravedi · 2022 · Clinical Kidney Journal
  30. Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa)
    Mélika Ben Ahmed, Hédia Bellali, Mariem Gdoura, Imen Zamali, Ouafa Kallala, Ahlem Ben Hmid, Walid Hamdi, Hela Ayari, Hajer Fares, Karim Mechri et al. · 2022 · Vaccines
  31. Small GTPase—A Key Role in Host Cell for Coronavirus Infection and a Potential Target for Coronavirus Vaccine Adjuvant Discovery
    Wei Hou, Sibei Wang, Heqiong Wu, Linli Xue, Bin Wang, Shouyu Wang, Haidong Wang · 2022 · Viruses
  32. Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination
    Jessica A. Breznik, Jessica A. Breznik, Angela Huynh, Ali Zhang, Lucas Bilaver, Hina Bhakta, Hannah D. Stacey, Jann Catherine Ang, Jonathan L. Bramson, Ishac Nazy et al. · 2022 · The Journal of Immunology
  33. Emerging Effects of IL-33 on COVID-19
    Yuan Gao, Luwei Cai, Lili Li, Yidan Zhang, Jing Li, Chengliang Luo, Ying Wang, Luyang Tao · 2022 · International Journal of Molecular Sciences
  34. SARS-CoV-2 infection and immune responses
    Rakhi Harne, Brittany Williams, Hazem F. M. Abdelaal, Susan L. Baldwin, Rhea N. Coler · 2023 · AIMS Microbiology
  35. Use of data mining approaches to explore the association between type 2 diabetes mellitus with SARS-CoV-2
    Hamideh Ghazizadeh, Neda Shakour, Sahar Ghoflchi, Amin Mansoori, Maryam Saberi‐Karimian, Mohammad Rashidmayvan, Gordon A. Ferns, Habibollah Esmaily, Majid Ghayour‐Mobarhan · 2023 · BMC Pulmonary Medicine
  36. ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
    T. Lambe, Alexandra J. Spencer, Kelly M. Thomas, K. Gooch, Stephen R. Thomas, A. White, H. Humphries, Daniel Wright, Sandra Belij-Rammerstorfer, Nazia Thakur et al. · 2021 · Communications Biology
  37. SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity
    Eric D. Laing, Nusrat J Epsi, Stephanie A Richard, Emily C Samuels, Wei Wang, Russell A. Vassell, Daniel F. Ewing, Rachel Herrup, Spencer L. Sterling, David A Lindholm et al. · 2021 · medRxiv
  38. Complement Activation Induces Excessive T Cell Cytotoxicity in Severe COVID-19
    Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, Sophia Brumhard, Laura Michalick, Lena Johanna Lippert, Tomislav Kostevc, Christiane Gäbel, Maria Schneider, Mathias Streitz et al. · 2021 · SSRN Electronic Journal
  39. COVID-19 clinical presentation, management, and epidemiology: a concise compendium
    David P. Maison, Hawi Tasissa, Amelia N. Deitchman, Michael J. Peluso, Youping Deng, F. DeWolfe Miller, Timothy J. Henrich, Mariana Gerschenson · 2025 · Frontiers in Public Health
  40. Challenges and Issues of Anti-SARS-CoV-2 Vaccines
    Sophie Blumental, Patrice Debré · 2021 · Frontiers in Medicine
  41. Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals
    Norihide Jo, Rui Zhang, Hideki Ueno, Takuya Yamamoto, Daniela Weiskopf, Miki Nagao, Shinya Yamanaka, Yoko Hamazaki · 2021 · Frontiers in Aging
  42. Patho-Physiology of Aging and Immune-Senescence: Possible Correlates With Comorbidity and Mortality in Middle-Aged and Old COVID-19 Patients
    Saba Farheen, Sudhanshu Agrawal, Swaleha Zubair, Anshu Agrawal, Fauzia Jamal, Ishrat Altaf, Abu Kashif Anwar, Syed Mohammad Umair, Mohammad Owais · 2021 · Frontiers in Aging
  43. Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
    Niels J. M. Verstegen, Ruth R. Hagen, Jet van den Dijssel, Lisan H Kuijper, Christine Kreher, Thomas M. Ashhurst, Laura Y. L. Kummer, Maurice Steenhuis, Mariël C Duurland, Rivka de Jongh et al. · 2022 · eLife
  44. Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people
    Joana Vitallé, Alberto Pérez‐Gómez, Francisco José Ostos, Carmen Gasca‐Capote, María Reyes Jiménez‐León, Sara Bachiller, Inmaculada Rivas‐Jeremías, Maria del Mar Silva-Sánchez, Anabel M. Ruiz-Mateos, María Ángeles Martín-Sánchez et al. · 2022 · JCI Insight
  45. Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19
    Magdalene Joseph, Yin Wu, Richard Dannebaum, Florian Rubelt, Iva Zlatareva, Anna Lorenc, Zhipei Gracie Du, Daniel Davies, Fernanda Kyle‐Cezar, Abhishek Das et al. · 2022 · Proceedings of the National Academy of Sciences
  46. Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity
    Daichao Wu, Grigory Aleksandrovich Efimov, Боголюбова Аполлинария Васильевна, Brian G. Pierce, Roy A. Mariuzza · 2023 · Journal of Biological Chemistry
  47. Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study
    Elena Vázquez‐Alejo, Laura Tarancón‐Díez, María de la Sierra Espinar-Buitrago, Miguel Genebat, Alba Calderón, Guillermo Pérez-Cabeza, Esmeralda Magro-López, Manuel Leal, María Ángeles Muñoz‐Fernández · 2023 · Journal of Clinical Medicine
  48. Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity
    Yuan Chen, Georgina H. Mason, David Oliver Scourfield, Alexander Greenshields‐Watson, Tracey A. Haigh, Andrew Kelvin Sewell, Heather M. Long, Awen Gallimore, P.J. Rizkallah, Bruce J. MacLachlan et al. · 2023 · Cell Reports
  49. HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID ‐19
    Patricia Castro-Santos, Augusto Rojas‐Martínez, José A. Riancho, Pablo Daniel Lapunzina, Carlos Flores, Ángel Carracedo, Roberto Díaz‐Peña, Scourge Cohort Group · 2023 · HLA
  50. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients
    Pierre-Gregoire A. Coulon, Swayam Prakash, Nisha Rajeswari Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F. Tifrea, Robert A. Edwards, Cesar J. Figueroa, Sebastian Dominik Schubl, Lanny L. Hsieh et al. · 2024 · Frontiers in Immunology
  51. Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants
    A. Chandrashekar, Jin-Yan Liu, Jing-You Yu, K. McMahan, Lisa H. Tostanoski, Catherine Jacob-Dolan, N. Mercado, Tochi Anioke, Aiquan Chang, Sarah Gardner et al. · 2021 · Science Translational Medicine
  52. A comprehensive assessment of long-term SARS-CoV-2–specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients
    Alexandre Favà, Laura Donadeu, Thomas Jouvé, José González‐Costello, Laura Lladó, Carolina Santana, Néstor Toapanta, Manuel Comabella, Vincent Pernin, Carme Facundo et al. · 2022 · Kidney International
  53. Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2
    Patrick C. Wilson, Christopher T. Stamper, Haley L. Dugan, Lei Li, Nicholas W. Asby, Peter Halfmann, Jenna J. Guthmiller, Nai‐Ying Zheng, Min Huang, Olivia Stovicek et al. · 2020 · Research Square
  54. Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative
    Isaac Kyei-Barffour, Samuel Akwetey Addo, E. Aninagyei, George Ghartey-Kwansah, D. O. Acheampong · 2021 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  55. Mucosal Immunity against SARS-CoV-2 in the Respiratory Tract
    Hae Eun Noh, Min‐Seok Rha · 2024 · Pathogens
  56. Adaptive immunity to human coronaviruses is widespread but low in magnitude
    Hyon‐Xhi Tan, Wen Shi Lee, Kathleen M. Wragg, Christina Nelson, Robyn Esterbauer, Hannah G. Kelly, Thakshila H. Amarasena, Robert M. Jones, Graham Starkey, Bao Zhong Wang et al. · 2021 · Clinical & Translational Immunology
  57. Immune response to COVID-19 in older adults
    Mladen Jergović, Christopher P. Coplen, Jennifer L. Uhrlaub, Janko Nikolich‐Žugich · 2021 · The Journal of Heart and Lung Transplantation
  58. T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19
    Mario Fernández‐Ruiz, Beatriz Olea, Patricia Almendro-Vázquez, Estela Giménez, Alberto Marcacuzco, Rafael San Juan, Iago Justo, Jorge Calvo, Álvaro García‐Sesma, Alejandro Manrique et al. · 2021 · American Journal of Transplantation
  59. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
    Min Kyung Jung, Eui‐Cheol Shin · 2021 · Molecules and Cells
  60. COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era
    Àngela Deyà‐Martínez, Ana García‐García, Europa Azucena González‐Navarro, L. Yiyi, Alexandru Daniel Vlagea, Iolanda Jordán, Vicky Fumadó, Clàudia Fortuny, Marta Español‐Rego, Cristian Launes et al. · 2021 · Clinical Immunology
  61. Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset
    Jaclyn C. Law, Mélanie Girard, Gary Y. C. Chao, Lesley A. Ward, Baweleta Isho, Bhavisha Rathod, Karen Colwill, Zhijie Li, James M. Rini, Feng Yun Yue et al. · 2021 · The Journal of Immunology
  62. Serum Neutralizing Antibody Titers 12 Months After Coronavirus Disease 2019 Messenger RNA Vaccination: Correlation to Clinical Variables in an Adult, US Population
    Min Zhao, Rebecca Slotkin, Amar H. Sheth, Lauren Pischel, Tassos C. Kyriakides, Brinda Emu, Cynthia F. McNamara, Qiaosu Shi, Jaden Delgobbo, Jin Xu et al. · 2022 · Clinical Infectious Diseases
  63. Tissue immunity to SARS‐CoV‐2: Role in protection and immunopathology*
    Ksenia Rybkina, Julia Davis‐Porada, Donna L. Färber · 2022 · Immunological Reviews
  64. Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine
    Kristopher K. Short, Stephanie K. Lathrop, Clara J. Davison, Haley A. Partlow, Johnathan A. Kaiser, Rebekah D. Tee, Elizabeth B. Lorentz, Jay T. Evans, David J. Burkhart · 2022 · Pharmaceutics
  65. Immune response induced by novel coronavirus infection
    Ying Sun, Yawen Zou, Haiyu Wang, Guangying Cui, Zujiang Yu, Zhigang Ren · 2022 · Frontiers in Cellular and Infection Microbiology
  66. Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination
    Takuto Nogimori, Koichiro Suzuki, Yuji Masuta, Mika Yagoto, Mami Ikeda, Yuki Katayama, Ayaka Washizaki, Hidenori Kanda, Minoru Takada, Shohei Minami et al. · 2023 · Frontiers in Immunology
  67. Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection
    Sanjeev Gurshaney, Anamaria Morales Alvarez, Kevin Ezhakunnel, Andrew Manalo, Thien-Huong Huynh, Jun‐ichi Abe, Nhat-Tu Le, Daniela Weiskopf, Alessandro Sette, Daniel S. Lupu et al. · 2023 · Communications Biology
  68. COVID-19 and Multiorgan Response: The Long-Term Impact
    Amer Harky, Avesta Ala'Aldeen, Sundas Butt, Bea Duric, Sakshi Roy, Mohamed Zeinah · 2023 · Current Problems in Cardiology
  69. An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
    Peter A. C. Wing, Nathalie M. Schmidt, Rory Peters, Maximilian Erdmann, Rachel L. Brown, Hao Wang, Leo Swadling, COVIDsortium Investigators, Joseph Newman, Nazia Thakur et al. · 2023 · PLoS Pathogens
  70. Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5
    Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz, Julie Sahler, Chengjin Ye, Ximena A. Olarte‐Castillo, Anna Zou, Cole T. Kwas, Katelyn O’Hare, Annette Choi et al. · 2023 · Science Advances
  71. SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors
    Cecily Choy, Joseph Chen, Jiangyuan Li, D. Travis Gallagher, Jian Lü, Daichao Wu, Ainslee Zou, Humza Hemani, Beverly A. Baptiste, Emily Wichmann et al. · 2023 · Nature Communications
  72. The characterization of CD8 + T-cell responses in COVID-19
    Yuanting Yang, H. I. Miller, Maria G. Byazrova, Fabio Cndotti, Kamel Benlagha, Niels Olsen Saraiva Câmara, Junming Shi, Huamei Fu Forsman, Pamela P. W. Lee, Lu Yang et al. · 2023 · Emerging Microbes & Infections
  73. Deconvoluting TCR-dependent and -independent activation is vital for reliable Ag-specific CD4 + T cell characterization by AIM assay
    Ming Z. M. Zheng, Lauren Burmas, Hyon‐Xhi Tan, Mai-Chi Trieu, Hyun Jae Lee, Daniel Rawlinson, Ashraful Haque, Stephen John Kent, Adam K. Wheatley, Jennifer A. Juno · 2025 · Science Advances
  74. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
    Min‐Seok Rha, A Reum Kim, Eui‐Cheol Shin · 2021 · Immune Network
  75. Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity
    A. Scaglione, S. Opp, A. Hurtado, C. Pampeno, Ziyan Lin, Maria G. Noval, Sara A. Thannickal, Kenneth A. Stapleford, D. Meruelo · 2021 · bioRxiv
  76. Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia
    Rowa Y. Alhabbab, Ahdab Alsaieedi, Abdullah A. Algaissi, Sarah A. Almahboub, Rajaa Mohammad Al-Raddadi, Omaima I. Shabouni, Rahaf Alhabbab, Abdulelah A. Alfaraj, Sawsan S. Alamri, Najwa D. Aljehani et al. · 2021 · Viruses
  77. Understanding T cell aging to improve anti-viral immunity
    Huimin Zhang, Cornelia M. Weyand, Jörg J. Goronzy, Claire E. Gustafson · 2021 · Current Opinion in Virology
  78. Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection
    Martin Sebastian Winkler, Ralf Alexander Claus, Mareike Schilder, Stefan Pöhlmann, Sina Maren Coldewey, Julian Grundmann, Torben Fricke, Onnen Moerer, Konrad Meissner, Michael W Bauer et al. · 2021 · Clinical Science
  79. SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs
    S. Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, L. Pearlman, Da-Yuan Chen, M. Bauer, Hannah B. Taylor, Hasahn L. Conway, C. Tomkins-Tinch, Yaara Finkel et al. · 2020 · bioRxiv
  80. SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19
    Giovanny J. Martínez-Colón, Kalani Ratnasiri, Richard Chen, Sizun Jiang, ELIZABETH J. ZANLEY, Arjun Rustagi, Renu Verma, Han M. Chen, Jason Randolph Andrews, Kirsten D. Mertz et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  81. The age again in the eye of the COVID-19 storm: evidence-based decision making
    María C. Martín, Aurora Jurado, Cristina Abad‐Molina, Antonio Orduña, Oscar Yarce, Ana M. Navas, Vanesa Cunill, Danilo Escobar, Francisco Boix, Sergio Burillo‐Sanz et al. · 2021 · Immunity & Ageing
  82. Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes
    Kerstin Renner, Tobias Schwittay, Sophia Chaabane, J. Gottschling, Christine Müller, Charlotte Tiefenböck, Jan-Niklas Salewski, Frederike Winter, Simone Buchtler, Saidou Balam et al. · 2021 · Nature Communications
  83. Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19
    Maria Laura De Angelis, Federica Francescangeli, Rachele Rossi, Alessandro Giuliani, Ruggero D. Maria, Ann Zeuner · 2021 · Viruses
  84. OMIP 078: A 31‐parameter panel for comprehensive immunophenotyping of multiple immune cells in human peripheral blood mononuclear cells
    Takuto Nogimori, Yuko Sugawara, Masaya Higashiguchi, Hirotomo Murakami, Hirofumi Akita, Shokichi Takahama, Satoshi Tanaka, Takuya Yamamoto · 2021 · Cytometry Part A
  85. Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
    Yi-Sheng Sun, Jingjing Zhou, Han-Ping Zhu, Fang Xu, Wen-Bin Zhao, Hangjing Lu, Zhen Wang, Shu-Qing Chen, Ping-Ping Yao, Jianmin Jiang et al. · 2021 · Viruses
  86. Characterization of SARS‐CoV‐2 and common cold coronavirus‐specific T‐cell responses in MIS‐C and Kawasaki disease children
    Li‐En Hsieh, Alba Grifoni, John Sidney, Chisato Shimizu, Hiroko Shike, Nanda Ramchandar, Elizabeth Moreno, Adriana H. Tremoulet, Jane C. Burns, Alessandra Franco · 2021 · European Journal of Immunology
  87. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions
    Michael J. Peluso, Joanna L. Donatelli, Timothy J. Henrich · 2021 · Translational research
  88. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents
    Hing Wai Tsang, Gilbert T. Chua, Kelvin Kai‐Wang To, Joshua Sung Chih Wong, Wenwei Tu, Janette Kwok, Wilfred Hing Sang Wong, Xiwei Wang, Yanmei Zhang, Jaime S. Rosa Duque et al. · 2021 · Frontiers in Immunology
  89. An efficient immunoassay for the B cell help function of SARS-CoV-2-specific memory CD4+ T cells
    Asgar Ansari, Shilpa Sachan, Bimal Prasad Jit, Ashok Kumar Sharma, Poonam Coshic, Alessandro Sette, Daniela Weiskopf, Nimesh Gupta · 2022 · Cell Reports Methods
  90. Competent immune responses to SARS-CoV-2 variants in older adults following two doses of mRNA vaccination
    Mladen Jergović, Jennifer L. Uhrlaub, Makiko Watanabe, Christine M. Bradshaw, Lisa M. White, Bonnie LaFleur, Taylor Edwards, Ryan S. Sprissler, Michael Worobey, Deepta Bhattacharya et al. · 2022 · Nature Communications
  91. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation
    Thiviya Darmarajan, Keshav Raj Paudel, Mayuren Candasamy, Jestin Chellian, Thiagarajan Madheswaran, Lakshmana Prabu Sakthivel, Bey Hing Goh, Piyush Kumar Gupta, Niraj Kumar Jha, Hari Prasad Devkota et al. · 2022 · Environmental Science and Pollution Research
  92. The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
    Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, Mazin A. A. Najm, Guzal N. Sobirova, Zarnigor Orifovna Bafoeva, Ahmed Taifi, Ola Kamal A. Alkadir, Yasser Fakri Mustafa, Rasoul Mirzaei et al. · 2022 · Journal of Medical Virology
  93. Integrated time-series transcriptomic and metabolomic analyses reveal different inflammatory and adaptive immune responses contributing to host resistance to PRRSV
    Qingqing Wu, Yu Han, Xianmeng Wu, Yuan Wang, Qiuju Su, Yang Shen, Kaifeng Guan, Jennifer J. Michal, Zhihua Jiang, Bang Liu et al. · 2022 · Frontiers in Immunology
  94. Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID‐19 survivors
    Chen Jia, Zhi-Guo Zhou, Wenjing Pan, Pan Zhang, Ming Yang, Ming Zhao, Bo Li, Ping Liu, Qian-Qian Zhang, Xiang-long Kong et al. · 2022 · Journal of Medical Virology
  95. Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device
    Woo Joo Kim, Christine C. Roberts, Joon Young Song, Jin Gu Yoon, Hye Seong, Hakjun Hyun, Hyojin Lee, Areum Gil, Yeeun Oh, Ji-Eun Park et al. · 2022 · International Journal of Infectious Diseases
  96. SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals
    Rongzhang He, Xingyu Zheng, Jian Zhang, Bo Liu, Qijie Wang, Qian Wu, Ziyan Liu, Fangfang Chang, Yabin Hu, Ting Xie et al. · 2023 · Signal Transduction and Targeted Therapy
  97. Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection
    Gang Yang, Jinpeng Cao, Jian Qin, Xinyue Mei, Shidong Deng, Yingjiao Xia, Jun Zhao, Junxiang Wang, Tao Luan, Daxiang Chen et al. · 2024 · Signal Transduction and Targeted Therapy
  98. COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire
    Nabila Seddiki, Martyn A. French · 2021 · Frontiers in Immunology
  99. Emerging role of air pollution and meteorological parameters in COVID‐19
    Chan‐Na Zhao, Xinyu Fang, Ya-Ting Feng, Xue-Hui Fang, Jun He, Hai‐Feng Pan · 2021 · Journal of Evidence-Based Medicine
  100. IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
    Judith Fraussen · 2022 · EBioMedicine